| 1 |
Zhang Y, Peng Y, Xia X. Autoimmune diseases and gut microbiota: a bibliometric and visual analysis from 2004 to 2022. Clin Exp Med 2023. [PMID: 36859447 DOI: 10.1007/s10238-023-01028-x] [Reference Citation Analysis]
|
| 2 |
Tancredi V, Licata G, Calabrese G, Buononato D, De Rosa A, Argenziano G, Gambardella A. Down syndrome and biological treatments in dermatology: Efficacy and safety in our real-life experience and review of literature. Australas J Dermatol 2023. [PMID: 36779423 DOI: 10.1111/ajd.14006] [Reference Citation Analysis]
|
| 3 |
Kıran TR, Otlu O, Karabulut AB. Oxidative stress and antioxidants in health and disease. LaboratoriumsMedizin 2023;0. [DOI: 10.1515/labmed-2022-0108] [Reference Citation Analysis]
|
| 4 |
Villarreal-Martinez A, Martinez-de-Villarreal LE, Gomez-Flores M, Chavez-Alvarez S, Cerda-Flores R, Ocampo-Candiani J, Ruiz-Herrera C, Rodriguez-Rivera MR, Villarreal-Perez JZ, Gonzalez-Gonzalez JG, Calvo-Anguiano G. Mitochondrial dysfunction: The pathological link between psoriasis and insulin resistance? J Eur Acad Dermatol Venereol 2023;37:340-7. [PMID: 36184894 DOI: 10.1111/jdv.18631] [Reference Citation Analysis]
|
| 5 |
Słuczanowska-Głabowska S, Staniszewska M, Marchlewicz M, Duchnik E, Łuczkowska K, Safranow K, Machaliński B, Pawlik A. Adiponectin, Leptin and Resistin in Patients with Psoriasis. J Clin Med 2023;12. [PMID: 36675592 DOI: 10.3390/jcm12020663] [Reference Citation Analysis]
|
| 6 |
Kong Y, Jiang J, Huang Y, Liu X, Jin Z, Li L, Wei F, Liu X, Yin J, Zhang Y, Tong Q, Chen H. Narciclasine inhibits phospholipase A2 and regulates phospholipid metabolism to ameliorate psoriasis-like dermatitis. Front Immunol 2022;13:1094375. [PMID: 36700214 DOI: 10.3389/fimmu.2022.1094375] [Reference Citation Analysis]
|
| 7 |
Atayoglu AT, Çapar AG, Basmisirlioglu E, Yasar Y, Aykemat Y, Guner Atayoglu A, Inanc N. Investigation of the Relationship between the Disease Severity and Quality of Life of Psoriasis Patients and Their Anthropometric Measurements and Diets. Healthcare (Basel) 2022;10. [PMID: 36421647 DOI: 10.3390/healthcare10112323] [Reference Citation Analysis]
|
| 8 |
Xu J, Chen H, Qian H, Wang F, Xu Y. Advances in the modulation of ROS and transdermal administration for anti-psoriatic nanotherapies. J Nanobiotechnology 2022;20:448. [PMID: 36242051 DOI: 10.1186/s12951-022-01651-y] [Reference Citation Analysis]
|
| 9 |
Tolba DA, Amin RH, Alorbani AM, Mamdouh Esmat S. Retinal vascular assessment in psoriatic patients with and without metabolic syndrome using optical coherence tomography angiography. Sci Rep 2022;12:16720. [PMID: 36202827 DOI: 10.1038/s41598-022-20307-3] [Reference Citation Analysis]
|
| 10 |
Khan AQ, Agha MV, Sheikhan KSA, Younis SM, Tamimi MA, Alam M, Ahmad A, Uddin S, Buddenkotte J, Steinhoff M. Targeting deregulated oxidative stress in skin inflammatory diseases: An update on clinical importance. Biomedicine & Pharmacotherapy 2022;154:113601. [DOI: 10.1016/j.biopha.2022.113601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Meehan EV, Wang K. Interleukin-17 Family Cytokines in Metabolic Disorders and Cancer. Genes 2022;13:1643. [DOI: 10.3390/genes13091643] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 12 |
Toussirot E, Gallais-sérézal I, Aubin F. The cardiometabolic conditions of psoriatic disease. Front Immunol 2022;13:970371. [DOI: 10.3389/fimmu.2022.970371] [Reference Citation Analysis]
|
| 13 |
Nowowiejska J, Baran A, Flisiak I. Fatty Acid-Binding Proteins in Psoriasis-A Review. Metabolites 2022;12:833. [PMID: 36144237 DOI: 10.3390/metabo12090833] [Reference Citation Analysis]
|
| 14 |
Chhabra S, Sahu S, Sharma K, Sharma M, Rani L, Minz R, Dogra S. Th17/IL-17, Immunometabolism and Psoriatic Disease: A Pathological Trifecta. Psoriasis - New Research 2022. [DOI: 10.5772/intechopen.102633] [Reference Citation Analysis]
|
| 15 |
Kearney N, Kirby B. Alcohol and Psoriasis for the Dermatologist: Know, Screen, Intervene. Am J Clin Dermatol 2022. [PMID: 35997945 DOI: 10.1007/s40257-022-00713-z] [Reference Citation Analysis]
|
| 16 |
Chen J, Qi H, Liu L, Niu Y, Yu S, Qin S, He L. Elevated cholesteryl ester transfer and phospholipid transfer proteins aggravated psoriasis in imiquimod-induced mouse models. Lipids Health Dis 2022;21:75. [PMID: 35982498 DOI: 10.1186/s12944-022-01684-0] [Reference Citation Analysis]
|
| 17 |
Tong N, Zhang Y, Yang A, Dai X, Hao S. The potency of common proinflammatory cytokines measurement for revealing the risk and severity of anxiety and depression in psoriasis patients. J Clin Lab Anal 2022;:e24643. [PMID: 35944185 DOI: 10.1002/jcla.24643] [Reference Citation Analysis]
|
| 18 |
Schielke L, Zimmermann N, Hobelsberger S, Steininger J, Strunk A, Blau K, Hernandez J, Künzel S, Ziegenbalg R, Rösing S, Beissert S, Abraham S, Günther C. Metabolic Syndrome in Psoriasis Is Associated With Upregulation of CXCL16 on Monocytes and a Dysbalance in Innate Lymphoid Cells. Front Immunol 2022;13:916701. [DOI: 10.3389/fimmu.2022.916701] [Reference Citation Analysis]
|
| 19 |
Merzel Šabović EK, Starbek Zorko M, Janić M. Killing Two Birds with One Stone: Potential Therapies Targeting Psoriasis and Atherosclerosis at the Same Time. Int J Mol Sci 2022;23:6648. [PMID: 35743091 DOI: 10.3390/ijms23126648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
